IV lidocaine for headaches after non‑traumatic subarachnoid hemorrhage
Official title: Lidocaine Infusion As A Treatment Modality For Headache Following Non-Traumatic Subarachnoid Hemorrhage: A Prospective, Single-Center, Observational Cohort Study
Run by University of Kansas Medical Center · NCT06582810 · Data updated 2026-11-12
This project will try an IV lidocaine infusion to see if it reduces moderate to severe headaches in adults who had a non‑traumatic subarachnoid hemorrhage.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Wichita, Kansas) |
| Status | Recruiting |
| Started | January 31, 2025 |
| Main results expected | October 2027 |
| Study ends | July 2028 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT06582810 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with non‑traumatic subarachnoid hemorrhage who are neurologically stable (Hunt and Hess ≤3), can give numeric pain scores, and have no contraindications to lidocaine.
✕Probably not a fit
Patients with traumatic subarachnoid hemorrhage, severe neurologic impairment (Hunt and Hess >3), chronic preexisting pain, prior aneurysm, or contraindications to lidocaine are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational project will give adults with non‑traumatic subarachnoid hemorrhage an intravenous lidocaine infusion as part of their headache treatment while collecting data on pain and safety. Patients will report numeric pain scores every two hours while awake for up to seven days, and clinicians will monitor for vasospasm as part of routine care. Inclusion requires age over 18, a Hunt and Hess score of 3 or less, and the ability to communicate pain scores; significant cardiac disease, arrhythmia, seizures, or prior lidocaine allergy exclude participants. The design is non-randomized and descriptive, so results will show safety and pain trends rather than prove definitive causation.
Why it matters
Potential benefit: If successful, IV lidocaine could provide a relatively fast and well-tolerated way to reduce severe post‑SAH headaches and improve patient comfort during recovery.
How similar studies have gone: Applying IV lidocaine to post‑SAH headache is relatively novel—small case reports and limited trials of IV lidocaine for refractory headache suggest possible benefit, but strong evidence in subarachnoid hemorrhage is lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \> 18 years; * Have a favorable neurological status defined as Hunt and Hess score ≤ 3 (as it accounts for patient awareness); * Can communicate numeric pain scores; * Are diagnosed with non-traumatic subarachnoid hemorrhage Exclusion Criteria: * The patient is diagnosed with traumatic subarachnoid hemorrhage; * If the patient is \< 18 years of age; * If numeric pain scores could not be captured for \> 3 days of hospitalization; * If the patient had a prior aneurysm; * Chronic pain not associated with non-traumatic subarachnoid hemorrhage diagnosis; * A disability before the stroke (\> 2 on modified Rankin Scale score); * A Hunt and Hess score \> 3; * Contraindications to lidocaine (significant cardiac disease, arrhythmia, seizures, previous allergic reaction to lidocaine
Where it's running
-
Ascension Via Christi St. Francis
Wichita, Kansas, United States Recruiting
Study contacts
- Principal investigator: Fernando Salgado, MD — University of Kansas Medical Center
- Study coordinator: William L Krogman, MS
- Email: wkrogman@kumc.edu
- Phone: 316-268-6156
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
Immediate neck manual therapy effects on atlas position and neck muscles
This trial tests two upper neck manual therapy techniques to see their immediate effect on neck alignment, atlas position, and a neck muscle shape in adults with head and neck pain or headaches.
-
Vitamin IV lidocaine before fundal pressure to prevent headache after cesarean using spinal anesthesia
This trial tests whether a single intravenous dose of lidocaine given before fundal pressure during cesarean delivery reduces the chance or severity of headache.
-
Muscle Position and Dry Needling Efficacy
This study tests whether the position of the upper trapezius during dry needling changes pain and function for people with chronic neck pain.
-
Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling
This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.
-
Surgical masks versus N95 masks for operating room nurses' symptoms from surgical smoke
This test compares whether surgical masks or N95 masks reduce physical symptoms from surgical smoke in operating room nurses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.